EDAP TMS SA

Company Overview and Strategy EDAP TMS S.A. ( EDAP, the Company, we, us, or our ) is a medical technology company focused on the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices. Our legal name is EDAP TMS S.A., and our commercial name is Focal One . We were founded in 1979 as a soci t anonyme organized under the laws of France for a duration of 60 years from the date of incorporation, unless extended by shareholder approval in accordance with French corporate law. We are headquartered in Vaulx-en-Velin, France and operate in the United States, Europe, Asia and the rest of the world. We are listed on The Nasdaq Global Market ( Nasdaq ) under the symbol EDAP. Our technologies are primarily used in urology, with a current focus on the treatment of prostate cancer. We are conducting clinical development activities to support potential expanded indications in urology and women’s health. We have realigned our business to focus exclusively on applications leveraging our proprietary High Intensity Focused Ultrasound ( HIFU ) technology, driven commercially by our flagship product, Focal One Robotic HIFU. This realignment is intended to position Focal One HIFU as a differentiated platform that we believe may support higher-margin growth opportunities over time.